Hellenbrand W E
Yale University School of Medicine, New Haven, Connecticut.
Curr Opin Cardiol. 1991 Feb;6(1):110-8. doi: 10.1097/00001573-199102000-00018.
The use of the pediatric cardiac catheterization laboratory as a therapeutic modality has become standard practice in most pediatric cardiology centers. Accordingly, reviewing the results of this form of therapy has become very important. This review focuses on the initial and long-term results of balloon dilation procedures in infants and children. As the efficacy and safety has been proven for these early procedures, dilatation therapy has become available for the critically ill neonate with pulmonary and aortic stenosis. The usefulness of implantable devices for closing abnormal shunt pathways, such as the patent ductus arteriosus and atrial septal defect, has become clear. The importance of both transthoracic color-flow Doppler and transesophageal echocardiography in proper placement and follow-up of these implantable devices is now becoming apparent and also will be evaluated in this review.
在大多数儿科心脏病中心,将儿科心导管实验室用作一种治疗手段已成为标准做法。因此,回顾这种治疗方式的结果变得非常重要。本综述重点关注婴儿和儿童球囊扩张术的初始和长期结果。由于这些早期手术的疗效和安全性已得到证实,扩张治疗已可用于患有肺动脉和主动脉狭窄的危重新生儿。植入式装置用于闭合异常分流通道(如动脉导管未闭和房间隔缺损)的效用已变得明确。经胸彩色血流多普勒和经食管超声心动图在这些植入式装置的正确放置和随访中的重要性现在正变得明显,并且也将在本综述中进行评估。